D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 49 Citations 7,022 114 World Ranking 2851 National Ranking 27

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Antibody

His primary areas of study are Immunology, Immune system, Pathology, Autoimmunity and Interleukin 12. All of his Immunology and Interleukin 21, Innate lymphoid cell, Innate immune system, Myelin oligodendrocyte glycoprotein and Microglia investigations are sub-components of the entire Immunology study. His work is dedicated to discovering how Immune system, Myelin are connected with Cell, Interleukin 18 and Autoantibody and other disciplines.

When carried out as part of a general Pathology research project, his work on Lesion is frequently linked to work in Glial fibrillary acidic protein, therefore connecting diverse disciplines of study. His Autoimmunity research incorporates elements of Autoimmune disease, Cytokine, Pancreas and Uterus. His Cytokine research incorporates themes from Myasthenia gravis, Acetylcholine receptor and FOXP3.

His most cited work include:

  • Organ-specific features of natural killer cells (252 citations)
  • Organ-specific features of natural killer cells (252 citations)
  • Natural killer cells determine the outcome of B cell–mediated autoimmunity (169 citations)

What are the main themes of his work throughout his whole career to date?

Fu-Dong Shi spends much of his time researching Immunology, Immune system, Neuromyelitis optica, Pathology and Internal medicine. His Myasthenia gravis, Cytokine, Experimental autoimmune encephalomyelitis, Autoimmunity and Autoimmune disease investigations are all subjects of Immunology research. He has researched Autoimmunity in several fields, including IL-2 receptor and Antigen.

His Immune system research includes elements of Interleukin 12 and Nicotine. His work deals with themes such as Neuromyelitis Optica Spectrum Disorders, Brain ischemia and Neurology, which intersect with Pathology. His biological study spans a wide range of topics, including Endocrinology, Rituximab, Cardiology, Gastroenterology and Polysomnography.

He most often published in these fields:

  • Immunology (75.50%)
  • Immune system (30.50%)
  • Neuromyelitis optica (30.00%)

What were the highlights of his more recent work (between 2015-2021)?

  • Neuromyelitis optica (30.00%)
  • Immunology (75.50%)
  • Pathology (28.50%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Neuromyelitis optica, Immunology, Pathology, Inflammation and Brain ischemia. The various areas that Fu-Dong Shi examines in his Neuromyelitis optica study include Aquaporin 4, Central nervous system, Grey matter, Spectrum disorder and Spinal cord. His Immunology research is multidisciplinary, incorporating perspectives in Receptor and Intracerebral hemorrhage.

His research in Pathology intersects with topics in White matter, Multiple sclerosis, Neurology and Ischemia. Fu-Dong Shi combines subjects such as Encephalomyelitis, Cytokine and Pathogenesis with his study of Inflammation. His work in Brain ischemia tackles topics such as Pharmacology which are related to areas like Fingolimod, Malondialdehyde, Dimethyl fumarate and Reperfusion injury.

Between 2015 and 2021, his most popular works were:

  • Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity (72 citations)
  • Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity (72 citations)
  • Colony stimulating factor 1 receptor inhibition eliminates microglia and attenuates brain injury after intracerebral hemorrhage (68 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Antibody

His scientific interests lie mostly in Inflammation, Brain ischemia, Pathology, Immunology and Immune system. His Inflammation research includes themes of Neurology, Neuroscience and Autoimmunity. His studies deal with areas such as Reperfusion injury, Dimethyl fumarate, Anesthesia and Pharmacology as well as Brain ischemia.

His Pathology study combines topics from a wide range of disciplines, such as Cellular immunity and Interleukin 15. The Immunology study combines topics in areas such as Receptor, Follicular phase and Cholinergic. The concepts of his Immune system study are interwoven with issues in Stroke, Interleukin 12 and Choline acetyltransferase.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Organ-specific features of natural killer cells

Fu-Dong Shi;Fu-Dong Shi;Hans-Gustaf Ljunggren;Antonio La Cava;Luc Van Kaer.
Nature Reviews Immunology (2011)

339 Citations

Natural killer cells determine the outcome of B cell–mediated autoimmunity

Shi Fd;Shi Fd;Wang Hb;Li H;Hong S.
Nature Immunology (2000)

254 Citations

IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells

Fu-Dong Shi;Fu-Dong Shi;Kiyoshi Takeda;Shizuo Akira;Nora Sarvetnick.
Journal of Immunology (2000)

235 Citations

Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.

Ying Fu;Junwei Hao;Ningnannan Zhang;Li Ren.
JAMA Neurology (2014)

218 Citations

Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology.

Junwei Hao;Ruolan Liu;Wenhua Piao;Qinghua Zhou.
Journal of Experimental Medicine (2010)

209 Citations

Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.

Zilong Zhu;Ying Fu;Decai Tian;Na Sun.
Circulation (2015)

206 Citations

Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen

Timothy L. Vollmer;Ruolan Liu;Mary Price;Susan Rhodes.
Journal of Immunology (2005)

184 Citations

Induction of Antigen-Specific Tolerance in Multiple Sclerosis After Immunization With DNA Encoding Myelin Basic Protein in a Randomized, Placebo-Controlled Phase 1/2 Trial

Amit Bar-Or;Timothy Vollmer;Jack Antel;Douglas L. Arnold.
JAMA Neurology (2007)

182 Citations

Impact of an immune modulator fingolimod on acute ischemic stroke.

Ying Fu;Ningnannan Zhang;Li Ren;Yaping Yan.
Proceedings of the National Academy of Sciences of the United States of America (2014)

169 Citations

Reciprocal regulation between natural killer cells and autoreactive T cells.

Fu-Dong Shi;Luc Van Kaer.
Nature Reviews Immunology (2006)

161 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fu-Dong Shi

Qiang Liu

Qiang Liu

Chinese Academy of Sciences

Publications: 36

Zhigang Tian

Zhigang Tian

University of Science and Technology of China

Publications: 28

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 28

Sara Fuchs

Sara Fuchs

Weizmann Institute of Science

Publications: 22

John H. Zhang

John H. Zhang

Loma Linda University

Publications: 18

Howard L. Weiner

Howard L. Weiner

Harvard University

Publications: 18

Lawrence Steinman

Lawrence Steinman

Stanford University

Publications: 17

Hans-Gustaf Ljunggren

Hans-Gustaf Ljunggren

Karolinska Institute

Publications: 17

Jie Zhu

Jie Zhu

Jilin University

Publications: 17

David J. Mooney

David J. Mooney

Harvard University

Publications: 16

Hans Link

Hans Link

Karolinska Institute

Publications: 15

Bao-Guo Xiao

Bao-Guo Xiao

Fudan University

Publications: 15

Amit Bar-Or

Amit Bar-Or

University of Pennsylvania

Publications: 14

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 14

Yenan T. Bryceson

Yenan T. Bryceson

University of Bergen

Publications: 13

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 13

Something went wrong. Please try again later.